By unraveling the intricate interaction between cell stress, chromatin remodeling, and NFκB signaling, we can ultimately develop more effective therapeutic strategies that not only target the initial tumor burden but also eradicate these elusive cancer stem-like cells, finally achieving durable remissions. Here, NFKB1 is linked to neoplasm.